This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Advances in molecular genetics and neuroimaging now support novel integrative studies of complex behavioral traits and brain disease.1 These phenomena connect multiple etiologies with common clinical end points of which Alzheimer disease (AD) is probably the best known. Twin studies reliably estimate the effect of environment on AD at approximately 20%,2 but how to disentangle the genetic and environmental factors in AD remains one of the greatest challenges in clinical neuroscience. The task requires understanding a complex matrix of data that comprises the myriad physical manifestations of neurodegenerative diseases arising in a multidimensional research space and occurring at multiple possible levels of enquiry that includes neurogenetics and neuroimaging and covers neurodevelopment and aging, childhood adversities, occupation, physical and mental health, and more. The potential reward is great: identification of neural pathways underpinning the harmful effects and novel types of intervention to prevent or delay AD. In this issue of Neurology, Shen et al.3 used UK Biobank data to make a unique contribution to this problem and show how, following a complex integrative analysis of epidemiologic, neuroimaging, and molecular genetic data, social isolation is linked to incident dementia. They added strong evidence of plausible pathways by showing an association between social isolation and reduced gray matter (GM) volumes and underexpressed genes already linked to AD.
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the editorial.
See page 55
- Received April 12, 2022.
- Accepted in final form April 18, 2022.
- © 2022 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
